Harnessing the Power of Data in Cancer Care: Data Sharing and Artificial Intelligence

Prof. Andre Dekker, PhD (1974) is a medical physicist and professor of Clinical Data Science at... Prof. Andre Dekker, PhD (1974) is a medical physicist and professor of Clinical Data Science at Maastricht University Medical Center and Maastro Clinic in The Netherlands. His Clinical Data Science research group (40 staff) focuses on 1) federated FAIR data infrastructures, 2) AI for health outcome prediction models and 3) applying AI to improve lives of patients and citizens. Prof. Dekker has authored over 200 publications mentored more than 30 PhD students and holds multiple awards and patents on the topic of federated data and AI. He has held visiting scientist appointments at universities and companies in the UK, Australia, Italy, USA and Canada. Read more Show less

Ceri Thompson is Deputy Head of the eHealth, Well-Being and Ageing Unit in DG CNECT and working... Ceri Thompson is Deputy Head of the eHealth, Well-Being and Ageing Unit in DG CNECT and working on the digital transformation of health and care, and the development of a European Health Data Space. Prior to working on digital health policy within the Commission, Ceri worked for Eurostat, and for DG SANTE. Before joining the EU institutions in 2002, Ceri worked on global health policy at the UK’s Department for International Development, for KPMG’s international healthcare practice, and on epidemiological research projects in the UK and Brazil. She has a degree in Mathematics from Durham University, UK and a Doctor of Public Health (DrPH) from the London School of Hygiene and Tropical Medicine. Read more Show less

David Anstatt is Vice President, Real-world Analytics and Data Sciences at Bristol-Myers Squibb.... David Anstatt is Vice President, Real-world Analytics and Data Sciences at Bristol-Myers Squibb. With deep experience in the development and use of real-world data resources for pharmaceutical development and commercialization, David is working to broaden data access and research capabilities to improve insights for R&D business partners, deepen the evidence base for new therapies and apply advanced analytics to a broad array of R&D challenges with the goal of improving outcomes for patients. David holds a MA in Economics from Wheaton College (IL), an MBA in Corporate Finance from Drexel University and an MPH in Epidemiology from the Johns Hopkins University Bloomberg School of Public Health. Read more Show less

Domenico D'Ugo is Full Professor of Surgery at Catholic University of Rome, “A.Gemelli” Medical... Domenico D'Ugo is Full Professor of Surgery at Catholic University of Rome, “A.Gemelli” Medical School. He has extensive practice in different and various fields of General, abdominal and thoracic surgery with high number of endoscopic exams throughout the first years plus >3000 surgical operations until June 2003, 2000 of them as first operating surgeon ( from the officla data bank of “A.Gemelli”University Hospital) > 1300 major oncologic treatments as responsible of the Surgical Oncology Unit at the “Centro ad alta Tecnologia per la formazione e ricerca nelle scienze biomediche”, sede di Campobasso UCSC(from the official data bank : S.I.S. Campobasso). From November 1st 2006, as the Director of the General Surgical Unit of “A.Gemelli” Hospital, has performed and/or supervised >800 medium-major procedures per year The peculiar personal experience that can be deducted from the complex of such yearly activity has been mainly focused on diverse aspect of surgical oncology techniques, starting from lung, esophageal, thyroid and breast surgery (during the years of service in Thoracic Surgery), up to the most recent interests in pancreas, colo-rectal and especially gastric neoplasms Peculiar attention has been deserved to the development, implementation and teaching of new technologies In all fields of abdominal surgery; has been initiator and leader of laparoscopic techniques at “A.Gemelli” Hospital” for cholecistectomy, anti-reflux procedures, splenectomy, laparoscopic colon resection for cancer and chronic inflammatort bowel diseases, laparoscopic anterior resection of the rectum and video-assisted Miles Operation; lately has initiated a program of laparoscopic D2 gastric resection. Administrative reports of all Surgical Unit directed by D.D’Ugo, up to date, witness for a very efficient organizational planing of an highly specialized level of surgical care, especially in the field of abdominal surgical oncology. Domenico D'Ugo is the current President of the European Society of Surgical Oncology (ESSO). Read more Show less

Gilly Spurrier-Bernard is Vice-Chair, Patient Advisory Committee, European Cancer... Gilly Spurrier-Bernard is Vice-Chair, Patient Advisory Committee, European Cancer Organisation Member, European Cancer Organisation's Patient Advisory Committee, Chair, WECAN and Member, Melanoma Patient Network Europe. A Geologist/Environmental Scientist by training, she began in Advocacy when her husband became a stage 4 Melanoma Patient in 2008. 2014-Present - President of MelanomeFrance - a patient Association run by volunteer Patients/Carers that provides up to date information on Melanoma Disease, Treatments, Clinical trials, Health Systems, Side Effect management and survivorship, as well as support for patients and their families. Moderation of a Forum of >900 Francophone Patients/Carers. Contributions to HTA evaluations for the HAS (French Evaluator), Contribution to selection of INCa Funded Projects, Lobbying of Stakeholders for access to treatments and clinical research. Contribution to research projects into PROs, Microbiome, rare cancers. 2016-Present - Vice-present of Melanoma Patient Network Europe - Participation in several initiatives, (Horizon 2020, IMI Get real, PRO research, and several European Projects) Planning and running several Patient and Multi-stakeholder Congresses each year : European, Regional, National, special group (Rare Melanoma s and paediatric) and Pan-Cancer meetings. Meetings and Advisory boards with all stakeholders: Regulators, HTA, Industry, Clinicians and Health Economists. 2019-Present - Chair of WECAN - Co-ordinating and communicating the joint activities/initiatives of 22 Pan-Cancer umbrella Organizations – Planning and Contributing the annual WECAN Academy for Cancer Patient Advocates, In January 2020 planned and ran the first WECAN Science training for Cancer patient advocates EUPATI fellow, Member of the European Cancer Organisation's Patient Advisory Committee, Project Partner on 2 Horizon 2020 Projects, Speaker at ESMO, the European Cancer Summit, EHA, several European Patient Conferences on topics from Fertility and Cancer, Combatting Pseudoscience, Immunotherapy Side effects, Value Frameworks and many more. Contributing to several publications : The European Cancer Organisation Essential Requirement for Quality Cancer Care in Melanoma, ASCO Melanoma Treatment Guidelines, ESMO Patient Guide for Immunotherapy Side Effects. I am passionate about patient education because well-informed patients are best equipped to lead the decision making in their treatment and hence cope better with their life as a melanoma patient/carer. I believe that Patient Advocates can drive better Patient relevant research through direct access to the primary data source and collaboration with other useful stakeholders. Read more Show less

Ivars Ijabs MEP is Vice-Chair, Special Committee on Beating Cancer (BECA)

EU Cancer Mission Board Member, Member of the European Cancer Organisation Executive Committee,... EU Cancer Mission Board Member, Member of the European Cancer Organisation Executive Committee, Digital Health Network Co-Chair Read more Show less

Professor Wim Oyen is Treasurer, European Cancer Organisation and Digital Health Network... Professor Wim Oyen is Treasurer, European Cancer Organisation and Digital Health Network Co-Chair. He is nuclear medicine physician at the Department of Radiology and Nuclear Medicine of Rijnstate Hospital, Arnhem, The Netherlands and full Professor of Diagnostic Imaging and Radiotherapy at Humanitas University in Milan, Italy. From 2015-2018, he was full Professor of Nuclear Medicine and Molecular Imaging at The Institute of Cancer Research and Head of the Department of Nuclear Medicine of The Royal Marsden Hospital, London, UK. Before working in the UK, he was a nuclear medicine physician and full Professor of Nuclear Medicine at the Radboud University Medical Centre Nijmegen, The Netherlands, serving as Head of the Department of Nuclear Medicine, Member of the Board of the Medical Staff and Director of the Research Institute for Oncology of RadboudUMC. Professor Oyen’s main research interests are molecular imaging in oncology and infectious diseases and radionuclide therapy of cancer. He is the (co-)author of more than 650 original science and review articles in international peer-reviewed journals. He is currently actively involved in the European Association of Nuclear Medicine (Board Member 2014-2020, past-Congress Chair 2015-2017 and EANM President 2019-2020), the International Cancer Imaging Society (member of the Board and the Trustees 2016-present, President 2017-2018) and in the European Cancer Organisation (Board member 2012-2016 and 2020-present, Treasurer 2014-2015, 2020-2021). Professor Oyen is a member of several Editorial Boards, including the European Journal of Nuclear Medicine and Molecular Imaging and the Journal of Nuclear Medicine. Read more Show less